Smart pancreas showdown: can Dual-Hormone tech beat low blood sugar?

NCT ID NCT06082973

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two versions of an artificial pancreas in 15 adults with type 1 diabetes. One version used only insulin with automatic carb suggestions, while the other added glucagon to prevent low blood sugar. Participants underwent exercise and meal challenges to see which system kept glucose levels safer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Locations

  • Hospital Clínico Universitario de Valencia

    Valencia, 46010, Spain